Using antibody staining and flow cytometry we observed that CD89 expression is higher on low-density compared to high-density neutrophils (Fig. 5E), supporting the findings in mice that CD89 expression is generally increased on tumor-associated myeloid cells. The gene discussed is FCAR; the disease is neoplasm.